ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

VIVIS CBD Gets First-Round Approval Enroute to Becoming Big Box Store Vendor

KATY, TX / ACCESSWIRE / May 13, 2021 / Neutra Corp. (OTC PINK:NTRR) is moving to the second step in the process of gaining acceptance as a vendor at one of three regional big box store chains. Upon successful completion, Neutra subsidiary VIVIS will be able to stock store shelves with its lab-tested CBD products and gain access to a wide range of new customers.

"We continue to make steady progress and are moving forward," said Neutra CEO Sydney Jim. "We're quite confident that these big box store chains will find that VIVIS CBD topicals and ingestibles will deliver great value and benefit to their customers. Our high-quality products are renowned for their certified potency and purity. When shoppers come across the VIVIS brand on big box store shelves and try them, both the customers and the stores will happy with the result."

VIVIS has already enjoyed great success at a smaller retail outlet in the Houston area. Neutra threw a VIVIS CBD product launch party at Restore Hyper Wellness in southwest Houston on May 1. The store nearly sold out of its initial allotment within hours and is now ordering additional stock to cope with demand.

VIVIS products are debuting this week at the Pasadena Medical Center Plaza Pharmacy, adjacent to the Pasadena Health Center.

With VIVIS products getting positive receptions from shoppers and retailers alike, Neutra is now considering additional business opportunities to generate new revenue streams and to build shareholder value. The company expects to make an announcement soon on potential new ventures to drive further growth.

About Neutra Corp.
Neutra Corp. (OTC PINK:NTRR) is an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food, and drug, and environmental purification sectors are creating a new kind of world culture-one where in which consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving hemp-based CBD market, in which the Company intends to participate. For more information, visit the Company's website at http://www.NeutraInc.com.

NOTICE REGARDING FORWARD-LOOKING STATEMENTS
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.

Neutra Contact:

Sydney Jim
888-433-4033
info@neutrainc.com

View source version on Accesswire.com.

SOURCE: Neutra Corp.



View source version on accesswire.com:
https://www.accesswire.com/646523/VIVIS-CBD-Gets-First-Round-Approval-Enroute-to-Becoming-Big-Box-Store-Vendor

Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.39
+0.00 (0.00%)
AAPL  264.72
+0.00 (0.00%)
AMD  198.62
+0.00 (0.00%)
BAC  49.81
+0.00 (0.00%)
GOOG  306.36
+0.00 (0.00%)
META  653.56
+0.00 (0.00%)
MSFT  398.55
+0.00 (0.00%)
NVDA  182.48
+0.00 (0.00%)
ORCL  149.25
+0.00 (0.00%)
TSLA  403.32
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.